Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit

被引:0
作者
Theodoros Karampatakis
Katerina Tsergouli
Lida Politi
Georgia Diamantopoulou
Elias Iosifidis
Charalampos Antachopoulos
Aggeliki Karyoti
Maria Sdougka
Athanassios Tsakris
Emmanuel Roilides
机构
[1] Aristotle University School of Health Sciences,Infectious Disease Unit, 3rd Department of Pediatrics, Medical Faculty
[2] Hippokration General Hospital,Microbiology Department
[3] Hippokration General Hospital,Microbiology Department
[4] National and Kapodistrian University School of Medicine,Infection Control Committee
[5] Hippokration General Hospital,Pediatric Intensive Care Unit
[6] Hippokration General Hospital,undefined
来源
Molecular Biology Reports | 2019年 / 46卷
关键词
Carbapenems; Microbial resistance; Pediatrics; Critical care;
D O I
暂无
中图分类号
学科分类号
摘要
We report a predominance (64.7%) of polyclonal carbapenem-resistant Acinetobacter baumannii (CRAB) strains concurrently producing OXA-23 and OXA-58 carbapenemases in a pediatric intensive care unit in an endemic area. This is the first report of emergence of such double-OXA CRAB strains in a single unit worldwide.
引用
收藏
页码:3497 / 3500
页数:3
相关论文
共 86 条
  • [1] Henig O(2015)Risk factors for and impact of carbapenem-resistant Eur J Clin Microbiol Infect Dis 34 2063-2068
  • [2] Weber G(2018) colonization and infection: matched case-control study Antimicrob Agents Chemother 12 801-815
  • [3] Hoshen MB(2017)Comparison of septic shock due to multidrug-resistant Future Microbiol 174 65-74
  • [4] Paul M(2015) or Eur J Pediatr 68 550-553
  • [5] German L(2013) carbapenemase-producing J Antimicrob Chemother 33 2233-2239
  • [6] Neuberger A(2017) in intensive care unit patients J Med Microbiol 49 749-753
  • [7] Gluzman I(1995)Molecular epidemiology of carbapenem-resistant J Clin Microbiol 24 136-141
  • [8] Berlin A(2017) in Greece: an extended review (2000–2015) Int J Antimicrob Agents 66 54-61
  • [9] Shapira C(2018)Successful management of an outbreak due to carbapenem-resistant Microb Drug Resist 15 212-224
  • [10] Balicer RD(2011) in a neonatal intensive care unit J Antimicrob Chemother undefined undefined-undefined